Screener
Denali Therapeutics Inc. DNLI Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Denali Therapeutics Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 11, 2025. Open the filing →
- Filed
- Aug 11, 2025
- Fiscal quarter
- Q2 FY2025
- Calendar quarter
- Q2 2025
- Accession
- 0001714899-25-000170
FAQ
- What is Denali Therapeutics Inc.'s net margin?
- Denali Therapeutics Inc. (DNLI) reported net margin of -33,121.9% in Q2 2024.
- How has Denali Therapeutics Inc.'s net margin changed year-over-year?
- Denali Therapeutics Inc.'s net margin decreased by 88424.2% year-over-year, from -37.4% to -33,121.9%.
- What is the long-term trend for Denali Therapeutics Inc.'s net margin?
- Over 3 years (2020 to 2023), Denali Therapeutics Inc.'s net margin has grown at a 27.5% compound annual growth rate (CAGR), from 21.2% to -43.9%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Denali Therapeutics Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude